Customers looking for an mRNA therapeutic partner should prioritize operational excellence and choose flexible CDMOs.

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

mRNA vaccine developer Moderna (MRNA) is sinking 9% after Goldman Sachs downgraded the shares to Neutral from Buy. Why ...

Scientists Katalin Kariko and Drew Weissmann have been awarded the 2023 Medicine Nobel Prize for their development of the mRNA technology for the production of Covid-19 vaccines, it was announced ...

Considering that PD-1/L1 are some of the most lucrative drug treatments across the industry, this could be a major coup for any mRNA developer that manages to successfully co-develop such a treatment.

They could also offer a more potent option to conventional flu shots, according to mRNA vaccine developers. Current flu vaccines generally offer only around 40% to 60% protective efficacy ...

The personalized cancer vaccine market is gaining rapid momentum, driven by biotech advancements and rising demand for targeted immunotherapies. The new 2025 report analyzes key players like BioNTech, ...

How does a COVID-19 mRNA vaccine work? COVID vaccines are now available. Some of the COVID-19 vaccines are mRNA vaccines, but what does this mean? mRNA vaccines are different from traditional ...